Finasteride-Induced Gynecomastia in a 62-Year-Old Man
- 30 June 1995
- journal article
- case report
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 309 (6) , 322-325
- https://doi.org/10.1097/00000441-199506000-00005
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- GynecomastiaNew England Journal of Medicine, 1993
- Prolonged treatment with finasteride (a 5α‐reductase inhibitor) does not affect bone density and metabolismClinical Endocrinology, 1992
- Hormonal Effects of a 5α-Reductase Inhibitor (Finasteride) on Hormonal Levels in Normal Men and in Patients with Benign Prostatic HyperplasiaEuropean Urology, 1991
- C19and C215β/5αMetabolite Ratios in Subjects Treated with the 5α-Reductase Inhibitor Finasteride: Comparison of Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency*Journal of Clinical Endocrinology & Metabolism, 1990
- Hormonal effects of an orally active 4‐azasteroid inhibitor of 5α‐reductase in humansThe Prostate, 1989
- 5α-Reductase inhibitory and anti-androgenic activities of some 4-azasteroids in the ratSteroids, 1986